This pathophysiology diagram illustrates the biochemical pathways of reactive oxygen species (ROS) production, detoxification, and their roles in oxidative stress and cell death. The process initiates with 'Xenobiotics' (e.g., heavy metals like Pb, pharmaceuticals, and environmental toxins), which are converted into free radicals via enzymes such as NADPH oxidases, xanthine oxidases, and Cytochrome P450. Key intermediates include the Superoxide anion (O₂⁻), which can react with Nitric oxide to form Peroxynitrite (ONOO⁻) or be converted by Superoxide Dismutase (SOD) into Hydrogen peroxide (H₂O₂). The diagram details two detoxification routes for H₂O₂: conversion to water and oxygen by Catalase, or to water by Glutathione peroxidase. Alternatively, H₂O₂ can undergo the Fenton reaction (involving Fe²⁺ to Fe³⁺ transition) to generate the highly reactive Hydroxyl radical (•OH). Downstream effects focus on the 'Imbalance between ROS production & antioxidant defenses,' leading to 'Damage to macromolecules' (proteins, lipids, and nucleic acids). The final clinical outcome depicted is 'Cell apoptosis,' represented by a morphological illustration of a fragmenting cell. This flowchart serves as an educational tool for understanding oxidative stress mechanisms and cellular pathology.

This pathophysiology diagram illustrates the biochemical mechanisms of cellular injury induced by ionizing radiation, specifically focusing on reactive oxygen species (ROS) and lipid peroxidation. The flowchart begins with ionizing radiation triggering the reduction of molecular oxygen (O2) into the superoxide radical (O2•-). This radical is converted via superoxide dismutase into hydrogen peroxide (H2O2), which can be neutralized by natural protective enzymes like catalase and glutathione peroxidase. However, in the presence of complexing metals (Fe, Cu), the Fenton and Haber-Weiss mechanisms facilitate the conversion of ROS into the highly reactive hydroxyl radical (•OH). The lower section details the pathological consequences of hydroxyl radicals, primarily lipid peroxidation of cell membranes. This process branches into two significant pathways: the generation of genotoxic species leading to oxidative DNA modification (represented by R•, RO•, and ROO• radicals) and the activation of the arachidonic acid cascade. The latter involves PG synthetases, lipoxygenase, and cyclooxygenase, ultimately producing inflammatory mediators such as prostaglandins, leukotrienes, and thromboxanes. The diagram serves as an educational tool for understanding radiation-induced oxidative stress and systemic inflammatory responses.

This pathophysiology diagram illustrates the comparative mechanism of action and stability of Epirubicin (EPI) and NC-6300 (an epirubicin-incorporating micelle) during sonodynamic therapy (SDT). Panel A depicts chemical stability against reactive oxygen species. It shows that free EPI is susceptible to hydroxyl radical (OH•) attack, leading to drug degradation, visually represented by fading red spheres. In contrast, NC-6300 features a protective hydrophilic shell (PEG-polyamino acid polymer) that shields the drug core from hydroxyl radicals, maintaining stability. Panel B demonstrates the sonosensitizing activity within an irradiation area. While both substances generate superoxide anions (O2•−) upon irradiation, NC-6300 shows accelerated generation compared to free EPI. This is graphically indicated by a higher density of O2•− symbols and larger radial sparks around the micellar structure. The diagram highlights two key pharmaceutical advantages of the NC-6300 nanocarrier: protection of the active moiety from premature degradation and enhanced therapeutic reactive oxygen species production for antitumor effects.